Sofwave cellulite technology receives FDA clearance
Medical device company Sofwave has received US Food and Drug Administration (FDA) clearance for a cellulite treatment to add to its SUPERB (synchronous ultrasound parallel beam) technology.
Medical device company Sofwave has received US Food and Drug Administration (FDA) clearance for a cellulite treatment to add to its SUPERB (synchronous ultrasound parallel beam) technology.
The latest addition to the Allergan body contouring portfolio of products, the CoolSculpting CoolTone, has received FDA clearance for improvement of abdominal tone, strengthening of the abdominal muscles, and development for a firmer abdomen.
On March 19 the Food and Drug Administration (FDA) issued letters of warning to two US breast implant manufacturers, Mentor Worldwide LLC and Sientra Inc.
The Food and Drug Administration (FDA) has approved Jeuveau, a botulinum toxin type A, for the temporary improvement in the appearance of moderate to severe glabellar lines.